Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike K Buchwald

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Colorectal Disease|October 9, 2015
Pelvic squamous cell cancer in an HIV-infected man with a history of high-grade anal dysplasiaUlrike K Buchwald
The American Journal of the Medical Sciences|March 28, 2013
A 33-year-old woman with fever, obtundation and diarrheaUlrike K Buchwald, Jonathan Young
The Journal of Infectious Diseases|February 10, 2021
Further Considerations on the Natural History of Anal Dysplasia in Response to Jongen et al and BarrosoSandy H Fang, Ulrike K Buchwald
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 24, 2021
The pipeline of new molecules and regimens against drug-resistant tuberculosisTodd A Black, Ulrike K Buchwald
Expert Review of Vaccines|November 18, 2022
Letter to the editor in response to: A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in childrenKristen Feemster, Natalie Banniettis, Ulrike K Buchwald
Human Vaccines & Immunotherapeutics|July 3, 2020
Response to Shami et al. 'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong' (Hum Vacc Immunother 2020)Ulrike K Buchwald, Temitope Folaranmi, Thomas Weiss
Current Opinion in Gastroenterology|July 24, 2020
The importance of anal cancer screening and high-resolution anoscopy to gastroenterology practiceKathy Bull-Henry, Bridget Morris, Ulrike K Buchwald
Microorganisms|October 27, 2022
Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>. <i>Microorganisms</i> 2022, <i>10</i>, 560Nicole Cossrow, Rennie Joshi, Kenneth Klinker, et al.
Infection and Immunity|December 25, 2004
A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in miceUlrike K Buchwald, Andrew Lees, Michael Steinitz, et al.
Expert Review of Vaccines|March 14, 2022
Response to Vyse et al., "A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK"Rachel Dawson, Ulrike K Buchwald, Kelly D Johnson, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Colorectal Disease|October 9, 2015
Pelvic squamous cell cancer in an HIV-infected man with a history of high-grade anal dysplasiaUlrike K Buchwald
The American Journal of the Medical Sciences|March 28, 2013
A 33-year-old woman with fever, obtundation and diarrheaUlrike K Buchwald, Jonathan Young
The Journal of Infectious Diseases|February 10, 2021
Further Considerations on the Natural History of Anal Dysplasia in Response to Jongen et al and BarrosoSandy H Fang, Ulrike K Buchwald
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 24, 2021
The pipeline of new molecules and regimens against drug-resistant tuberculosisTodd A Black, Ulrike K Buchwald
Expert Review of Vaccines|November 18, 2022
Letter to the editor in response to: A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in childrenKristen Feemster, Natalie Banniettis, Ulrike K Buchwald
Human Vaccines & Immunotherapeutics|July 3, 2020
Response to Shami et al. 'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong' (Hum Vacc Immunother 2020)Ulrike K Buchwald, Temitope Folaranmi, Thomas Weiss
Current Opinion in Gastroenterology|July 24, 2020
The importance of anal cancer screening and high-resolution anoscopy to gastroenterology practiceKathy Bull-Henry, Bridget Morris, Ulrike K Buchwald
Microorganisms|October 27, 2022
Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>. <i>Microorganisms</i> 2022, <i>10</i>, 560Nicole Cossrow, Rennie Joshi, Kenneth Klinker, et al.
Infection and Immunity|December 25, 2004
A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in miceUlrike K Buchwald, Andrew Lees, Michael Steinitz, et al.
Expert Review of Vaccines|March 14, 2022
Response to Vyse et al., "A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK"Rachel Dawson, Ulrike K Buchwald, Kelly D Johnson, et al.
Pageof 6